UK:
CJEU Overturns Neurim – No SPCs For New Therapeutic Uses Of Old Active Ingredients
13 July 2020
J A Kemp LLP
To print this article, all you need is to be registered or login on Mondaq.com.
The CJEU issued on 9 July 2020 its judgment in the Santen
C-673/18 case. The judgment, which is reviewed in more detail in
our briefing (here), overturns the earlier Neurim decision
and concludes that SPCs are not available for new therapeutic uses
of old active ingredients.
Originally published 10 July 2020.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Litigation, Mediation & Arbitration from UK
Costs, Actually: A Recap On Offers To Settle
Gatehouse Chambers
Hugh Grant has put civil costs on the public radar, in his latest thread on X (formerly Twitter) (via: @HackedOffHugh), concerning the settlement of his privacy claim against The Sun.